再次翻修全膝关节置换术的生存率显著低于首次翻修
单中心回顾性研究比较2016至2022年无菌性首次翻修全膝关节置换术850例与再次翻修178例,再次翻修组3.5年无全因翻修生存率75% vs 91%,1.5年无假体周围感染翻修生存率93% vs 98%,末次随访膝关节损伤与骨关节炎结局评分关节置换版62 vs 69。
要点
- 再次翻修组3.5年无全因翻修生存率75%,显著低于首次翻修组91%(P<0.0001)。
- 再次翻修组全因失败33例(19%)多于首次翻修组55例(6%)(P<0.0001)。
- 再次翻修组手术时间173 vs 160分钟、住院3.7 vs 3.2天均更长。
核心结论
- 与首次翻修全膝关节置换术相比,再次翻修全膝关节置换术在3.5年无全因翻修生存率(58% vs 43%)和2年无假体周围感染翻修生存率(91% vs 98%)方面显著降低。
- 作者认为,在卓越中心优化再次翻修全膝关节置换术患者的诊疗可能改善这些复杂患者的结局与照护。
研究设计与样本
- 单中心回顾性研究,纳入2016年至2022年无菌性翻修全膝关节置换术,首次翻修850例、再次翻修178例。
- 平均年龄67岁,女性占58%,平均体重指数31。
主要发现
- 再次翻修组手术时间173分钟 vs 首次翻修组160分钟(P=0.02),住院时间3.7天 vs 3.2天(P=0.0007)。
- 3.5年无全因翻修生存率再次翻修组75% vs 首次翻修组91%(P<0.0001)。
- 1.5年无假体周围感染翻修生存率再次翻修组93% vs 首次翻修组98%(P=0.003)。
- 全因失败再次翻修组33例(19%)vs 首次翻修组55例(6%)(P<0.0001);假体周围感染失败再次翻修组13例(7%)vs 首次翻修组17例(2%)(P=0.0001)。
- 末次随访膝关节损伤与骨关节炎结局评分关节置换版再次翻修组62 vs 首次翻修组69(P=0.01)。
关键数值与推荐
- 失败定义为全因翻修或假体周围感染翻修。
- 3.5年无全因翻修生存率再次翻修组75% vs 首次翻修组91%(P<0.0001)。
- 1.5年无假体周围感染翻修生存率再次翻修组93% vs 首次翻修组98%(P=0.003)。
- 末次随访膝关节损伤与骨关节炎结局评分关节置换版再次翻修组62 vs 首次翻修组69(P=0.01)。
临床怎么用
- 作者认为,在卓越中心优化再次翻修全膝关节置换术患者的诊疗可能改善这些复杂患者的结局与照护。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Revision total knee arthroplasty (rTKA) is an increasingly common challenge for arthroplasty surgeons. Compared to first-time rTKA, re-rTKA presents additional challenges, including further compromised soft tissues and bone loss, abundant scar tissue, stemmed revision implants, and metaphyseal fixation. The goal of this study was to compare the survivorship and clinical outcomes of aseptic first-time rTKAs and re-rTKAs. METHODS: A retrospective review of aseptic rTKAs from a single institution from 2016 to 2022 identified 850 first-time rTKAs and 178 re-rTKAs. The mean age was 67 years, 58% were women, and the mean body mass index was 31. The mean operative time was longer for re-rTKAs (173 versus 160 minutes, P = 0.02), as was the hospital length of stay for the re-rTKA cohort (3.7 versus 3.2 days, P = 0.0007). Failure was defined as all-cause revision or revision for periprosthetic joint infection (PJI). RESULTS: At 3.5 years, re-rTKAs had significantly lower survivorship free from all-cause revision than the first-time rTKA cohort (75 versus 91%, P < 0.0001). At 1.5 years, re-rTKAs had significantly lower survivorship free from revision for PJI than the first-time rTKA cohort (93 versus 98%, P = 0.003). Overall, the re-rTKA cohort had more all-cause failures (33 [19%] versus 55 [6%]; P < 0.0001) and more PJI failures (13 [7%] versus 17 [2%]; P = 0.0001). At the final follow up, the re-rTKA cohort had a significantly lower Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (62 versus 69, P = 0.01). CONCLUSIONS: Compared to first-time rTKA, re-rTKA has significantly decreased survivorship free from all-cause revision at 3.5 years (58 versus 43%) and revision for PJI at 2 years (91 versus 98%). Optimization of care for rTKA patients at centers of excellence may improve the outcomes and care of these complex patients.
引用
- Neitzke CC, Nocon AA, Bhatti P, et al. Repeat Revision Total Knee Arthroplasty Has Significantly Lower Survivorship Compared to First-Time Revisions. J Arthroplasty. 2025. PMID: 40349872. doi:10.1016/j.arth.2025.04.085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。